Atorvastatin Calcium Tablet
Product Images NDC 68071-3882

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 01)

Chemical structure of atorvastatin calcium, showing detailed molecular bonds and components including calcium ions and water molecules associated with the compound.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 02)

A line chart comparing cumulative incidence percentages over 3.5 years for Atorvastatin versus Placebo. The solid line represents Atorvastatin, showing a lower cumulative incidence than the dashed line for Placebo. The chart includes a hazard ratio (HR) of 0.64 and a p-value of 0.0005, indicating statistical analysis results.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 03)

A line graph showing cumulative hazard percentages over a five-year follow-up period comparing Atorvastatin and placebo groups. The x-axis represents time in years to the first primary endpoint through four years, while the y-axis indicates cumulative hazard percentage. The graph includes hazard ratio data (HR 0.63, 95% CI 0.48-0.83) with a p-value of 0.001.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 04)

A line graph showing the time to first major cardiovascular endpoint over 5 years for subjects taking Atorvastatin 10 mg and 80 mg. The y-axis represents the percentage of subjects experiencing the event, while the x-axis shows years. Two lines compare the incidence rate between the two doses with a hazard ratio (HR) of 0.78 (0.69-0.89) and a p-value of 0.0002 indicating statistical analysis results.*

FDA Label Image

Pdp (68071 3882 9)

Atorvastatin Calcium 40 mg tablets bottle label from NuCare Pharmaceuticals, Inc. The label states the package contains 90 film-coated tablets, each containing atorvastatin calcium equivalent to 40 mg atorvastatin. It includes manufacturer details by Gravitti Pharmaceuticals Pvt. Ltd., India, lot and expiration information, patient instructions, and storage directions to keep at controlled temperature 68-77°F. The label also includes barcodes, serial numbers, and a warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.